These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 8364901

  • 1. Tumor promotion in a breast cancer model by exposure to a weak alternating magnetic field.
    Löscher W, Mevissen M, Lehmacher W, Stamm A.
    Cancer Lett; 1993 Jul 30; 71(1-3):75-81. PubMed ID: 8364901
    [Abstract] [Full Text] [Related]

  • 2. Acceleration of mammary tumorigenesis by exposure of 7,12-dimethylbenz[a]anthracene-treated female rats in a 50-Hz, 100-microT magnetic field: replication study.
    Mevissen M, Häussler M, Lerchl A, Löscher W.
    J Toxicol Environ Health A; 1998 Mar 13; 53(5):401-18. PubMed ID: 9515942
    [Abstract] [Full Text] [Related]

  • 3. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
    Thun-Battersby S, Mevissen M, Löscher W.
    Cancer Res; 1999 Aug 01; 59(15):3627-33. PubMed ID: 10446973
    [Abstract] [Full Text] [Related]

  • 4. Linear relationship between flux density and tumor co-promoting effect of prolonged magnetic field exposure in a breast cancer model.
    Löscher W, Mevissen M.
    Cancer Lett; 1995 Sep 25; 96(2):175-80. PubMed ID: 7585454
    [Abstract] [Full Text] [Related]

  • 5. Exposure of DMBA-treated female rats in a 50-Hz, 50 microTesla magnetic field: effects on mammary tumor growth, melatonin levels, and T lymphocyte activation.
    Mevissen M, Lerchl A, Szamel M, Löscher W.
    Carcinogenesis; 1996 May 25; 17(5):903-10. PubMed ID: 8640936
    [Abstract] [Full Text] [Related]

  • 6. A histopathological study on alterations in DMBA-induced mammary carcinogenesis in rats with 50 Hz, 100 muT magnetic field exposure.
    Baum A, Mevissen M, Kamino K, Mohr U, Löscher W.
    Carcinogenesis; 1995 Jan 25; 16(1):119-25. PubMed ID: 7834796
    [Abstract] [Full Text] [Related]

  • 7. Study on pineal function and DMBA-induced breast cancer formation in rats during exposure to a 100-mG, 50 Hz magnetic field.
    Mevissen M, Lerchl A, Löscher W.
    J Toxicol Environ Health; 1996 Jun 07; 48(2):169-85. PubMed ID: 8642624
    [Abstract] [Full Text] [Related]

  • 8. Effects of magnetic fields on mammary tumor development induced by 7,12-dimethylbenz(a)anthracene in rats.
    Mevissen M, Stamm A, Buntenkötter S, Zwingelberg R, Wahnschaffe U, Löscher W.
    Bioelectromagnetics; 1993 Jun 07; 14(2):131-43. PubMed ID: 8494555
    [Abstract] [Full Text] [Related]

  • 9. Effects of weak alternating magnetic fields on nocturnal melatonin production and mammary carcinogenesis in rats.
    Löscher W, Wahnschaffe U, Mevissen M, Lerchl A, Stamm A.
    Oncology; 1994 Jun 07; 51(3):288-95. PubMed ID: 8196914
    [Abstract] [Full Text] [Related]

  • 10. Do cocarcinogenic effects of ELF electromagnetic fields require repeated long-term interaction with carcinogens? Characteristics of positive studies using the DMBA breast cancer model in rats.
    Löscher W.
    Bioelectromagnetics; 2001 Dec 07; 22(8):603-14. PubMed ID: 11748679
    [Abstract] [Full Text] [Related]

  • 11. Effect of 13 week magnetic field exposures on DMBA-initiated mammary gland carcinomas in female Sprague-Dawley rats.
    Anderson LE, Boorman GA, Morris JE, Sasser LB, Mann PC, Grumbein SL, Hailey JR, McNally A, Sills RC, Haseman JK.
    Carcinogenesis; 1999 Aug 07; 20(8):1615-20. PubMed ID: 10426815
    [Abstract] [Full Text] [Related]

  • 12. Effect of 26 week magnetic field exposures in a DMBA initiation-promotion mammary gland model in Sprague-Dawley rats.
    Boorman GA, Anderson LE, Morris JE, Sasser LB, Mann PC, Grumbein SL, Hailey JR, McNally A, Sills RC, Haseman JK.
    Carcinogenesis; 1999 May 07; 20(5):899-904. PubMed ID: 10334209
    [Abstract] [Full Text] [Related]

  • 13. Exposure of Fischer 344 rats to a weak power frequency magnetic field facilitates mammary tumorigenesis in the DMBA model of breast cancer.
    Fedrowitz M, Löscher W.
    Carcinogenesis; 2008 Jan 07; 29(1):186-93. PubMed ID: 17916910
    [Abstract] [Full Text] [Related]

  • 14. In vivo exposure of rats to a weak alternating magnetic field increases ornithine decarboxylase activity in the mammary gland by a similar extent as the carcinogen DMBA.
    Mevissen M, Kietzmann M, Löscher W.
    Cancer Lett; 1995 Apr 14; 90(2):207-14. PubMed ID: 7736457
    [Abstract] [Full Text] [Related]

  • 15. Chronic exposure to a GSM-like signal (mobile phone) does not stimulate the development of DMBA-induced mammary tumors in rats: results of three consecutive studies.
    Bartsch H, Bartsch C, Seebald E, Deerberg F, Dietz K, Vollrath L, Mecke D.
    Radiat Res; 2002 Feb 14; 157(2):183-90. PubMed ID: 11835682
    [Abstract] [Full Text] [Related]

  • 16. NTP Studies of Magnetic Field Promotion (DMBA Initiation) in Female Sprague-Dawley Rats (Whole-body Exposure/Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1999 Aug 14; 489():1-148. PubMed ID: 12563342
    [Abstract] [Full Text] [Related]

  • 17. Significant differences in the effects of magnetic field exposure on 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in two substrains of Sprague-Dawley rats.
    Fedrowitz M, Kamino K, Löscher W.
    Cancer Res; 2004 Jan 01; 64(1):243-51. PubMed ID: 14729631
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alterations in ornithine decarboxylase activity in the rat mammary gland after different periods of 50 Hz magnetic field exposure.
    Mevissen M, Häussler M, Löscher W.
    Bioelectromagnetics; 1999 Sep 01; 20(6):338-46. PubMed ID: 10453061
    [Abstract] [Full Text] [Related]

  • 20. Mammary tumours in Sprague-Dawley rats after initiation with DMBA followed by exposure to 50 Hz electromagnetic fields in a promotional scheme.
    Ekström T, Mild KH, Holmberg B.
    Cancer Lett; 1998 Jan 16; 123(1):107-11. PubMed ID: 9461026
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.